Calming Days Vegan Sunscreen

Diethylamino Hydroxybenzoyl Hexyl Benzoate, Octyl Triazone (ethylhexyl Triazone), Bisoctrizole, Diethylhexyl Butamido Triazone


Merci Co.
Human Otc Drug
NDC 83020-301
Calming Days Vegan Sunscreen also known as Diethylamino Hydroxybenzoyl Hexyl Benzoate, Octyl Triazone (ethylhexyl Triazone), Bisoctrizole, Diethylhexyl Butamido Triazone is a human otc drug labeled by 'Merci Co.'. National Drug Code (NDC) number for Calming Days Vegan Sunscreen is 83020-301. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Calming Days Vegan Sunscreen drug includes Bisoctrizole - 2 g/100mL Diethylamino Hydroxybenzoyl Hexyl Benzoate - 3 g/100mL Ethylhexyl Triazone - 2.4 g/100mL Iscotrizinol - 1.2 g/100mL . The currest status of Calming Days Vegan Sunscreen drug is Active.

Drug Information:

Drug NDC: 83020-301
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Calming Days Vegan Sunscreen
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Diethylamino Hydroxybenzoyl Hexyl Benzoate, Octyl Triazone (ethylhexyl Triazone), Bisoctrizole, Diethylhexyl Butamido Triazone
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Merci Co.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:BISOCTRIZOLE - 2 g/100mL
DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE - 3 g/100mL
ETHYLHEXYL TRIAZONE - 2.4 g/100mL
ISCOTRIZINOL - 1.2 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 18 Oct, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Merci Co.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:8NT850T0YS
ANQ870JD20
XQN8R9SAK4
2UTZ0QC864
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
83020-301-0150 mL in 1 TUBE (83020-301-01)18 Oct, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose sunscreen

Product Elements:

Calming days vegan sunscreen diethylamino hydroxybenzoyl hexyl benzoate, octyl triazone (ethylhexyl triazone), bisoctrizole, diethylhexyl butamido triazone coco-caprylate/caprate dibutyl adipate glycerin abies sibirica leaf oil potato pulp chamaemelum nobile flower oil diethylamino hydroxybenzoyl hexyl benzoate diethylamino hydroxybenzoyl hexyl benzoate water decyl glucoside xanthan gum tocopherol polymethylsilsesquioxane (4.5 microns) pelargonium graveolens flower oil clove leaf oil pogostemon cablin leaf oil anhydrous dextrose peg-9 diglycidyl ether/sodium hyaluronate crosspolymer tert-butyl alcohol 1,2-hexanediol xylitylglucoside butylene glycol propanediol bisoctrizole bisoctrizole polyquaternium-51 (2-methacryloyloxyethyl phosphorylcholine/n-butyl methacrylate; 3:7) iscotrizinol iscotrizinol caprylyl trisiloxane docosanol polyglyceryl-3 methylglucose distearate behenyl acrylate polymer olive oil rosemary oil chamomile flower oil acrylates crosspolymer-4 sodium stearoyl glutamate ammonium acryloyldimethyltaurate, dimethylacrylamide, lauryl methacrylate and laureth-4 methacrylate copolymer, trimethylolpropane triacrylate crosslinked (45000 mpa.s) tromethamine ascorbic acid adenosine centella asiatica triterpenoids juniperus deppeana wood oil diisopropyl sebacate ethylhexyl triazone ethylhexyl triazone carbomer homopolymer, unspecified type niacinamide anhydroxylitol xylitol pentylene glycol clary sage oil ethylhexylglycerin aloe vera leaf

Indications and Usage:

Uses • helps prevent sunburn • if used as directed with other sun protection measures (see directions). decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings:

Warnings for external use only

Do Not Use:

Warnings for external use only

When Using:

Warnings when using this product keep out of eyes. rinse with water to remove

Dosage and Administration:

Directions • apply evenly 15 minutes before sun exposure • reapply: • at least every 2 hours • use a water resistant sunscreen if swimming or sweating • sun protection measures. spending time in the sun increase your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m.-2 p.m. • wear long-sleeve shirts, pants, hats, and sunglasses • children under 6 months: ask a doctor

Stop Use:

Warnings stop use and ask a doctor if rash occurs

Package Label Principal Display Panel:

Display panel 83020-301-01


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.